vivus inc (VVUS:NASDAQ GS)
Earnings & Estimates Summary - VIVUS INC (VVUS)
2013 revenues at VIVUS Inc. totaled $81.1M USD, while annual losses equaled $1.41 per share.
Quarterly Earnings & Estimates - VIVUS INC (VVUS)
VIVUS Inc.'s Quarterly Earnings
VIVUS Inc. reported 2nd quarter 2014 losses of $0.25 per share on 08/9/2014.
Annual Earnings & Estimates - VIVUS INC (VVUS)
VIVUS Inc.'s Annual Earnings
VIVUS Inc. reported annual 2013 losses of $1.41 per share on 02/26/2014.
Quarterly Revenues - VIVUS INC (VVUS)
VIVUS Inc.'s Quarterly Revenues
VIVUS Inc. had 2nd quarter 2014 revenues of $21.9M USD. This bettered the $15.1M USD consensus of the 8 analysts covering the company. This was 295.4% above the prior year's 2nd quarter results.
Annual Revenues - VIVUS INC (VVUS)
VIVUS Inc.'s Annual Revenues
VIVUS Inc. had revenues for the full year 2013 of $81.1M USD. This was 3,929.9% above the prior year's results.
|Arena Pharmaceuticals Inc||$4.10 USD||+0.11|
|GlaxoSmithKline Consumer Healthcare Ltd||6,226 INR||+46.00|
|Novo Nordisk A/S||kr393.00 DKK||+4.40|
|Orexigen Therapeutics Inc||$4.36 USD||+0.15|
|Takeda Pharmaceutical Co Ltd||¥6,068 JPY||-40.00|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|